BACKGROUND: Phosphodiesterase 4D (PDE4D), through the regulation of cyclic AMP, modulates inflammation and other processes that affect atherosclerosis and stroke. A PDE4D polymorphism, single-nucleotide polymorphism (SNP) 83 (rs966221), is associated with ischemic stroke. The association of SNP 83 with postoperative cognitive dysfunction has never been investigated. OBJECTIVE: To determine whether SNP 83 is associated with cognitive dysfunction 1 day and 1 month following carotid endarterectomy (CEA). METHODS: Three hundred fourteen patients with high-grade carotid stenosis scheduled for CEA consented to participate in this single-center cohort study of cognitive dysfunction. RESULTS: Patients with the C/C genotype of SNP 83 exhibited significantly more cognitive dysfunction at 1 day (29.7%) than the C/T (15.8%, P = .008) and T/T (12.7%, P = .01) genotypes. In a multivariate logistic regression model, C/T and T/T genotypes were both associated with significantly decreased odds of cognitive dysfunction compared with the C/C genotype (odds ratio, 0.45 [0.24-0.83], P = .01 and odds ratio, 0.33 [0.12-0.77], P = .02). There were no significant associations at 1 month. CONCLUSION: The C/C genotype of SNP 83 is significantly associated with the highest incidence of cognitive dysfunction 1 day following CEA in comparison with the C/T and T/T genotypes. This PDE4D genotype may lead to accelerated cyclic AMP degradation and subsequently elevated inflammation 1 day after CEA. These observations, in conjunction with previous studies, suggest that elevated inflammatory states may be partially responsible for the development of cognitive dysfunction after CEA, but more investigation is required.
BACKGROUND:Phosphodiesterase 4D (PDE4D), through the regulation of cyclic AMP, modulates inflammation and other processes that affect atherosclerosis and stroke. A PDE4D polymorphism, single-nucleotide polymorphism (SNP) 83 (rs966221), is associated with ischemic stroke. The association of SNP 83 with postoperative cognitive dysfunction has never been investigated. OBJECTIVE: To determine whether SNP 83 is associated with cognitive dysfunction 1 day and 1 month following carotid endarterectomy (CEA). METHODS: Three hundred fourteen patients with high-grade carotid stenosis scheduled for CEA consented to participate in this single-center cohort study of cognitive dysfunction. RESULTS:Patients with the C/C genotype of SNP 83 exhibited significantly more cognitive dysfunction at 1 day (29.7%) than the C/T (15.8%, P = .008) and T/T (12.7%, P = .01) genotypes. In a multivariate logistic regression model, C/T and T/T genotypes were both associated with significantly decreased odds of cognitive dysfunction compared with the C/C genotype (odds ratio, 0.45 [0.24-0.83], P = .01 and odds ratio, 0.33 [0.12-0.77], P = .02). There were no significant associations at 1 month. CONCLUSION: The C/C genotype of SNP 83 is significantly associated with the highest incidence of cognitive dysfunction 1 day following CEA in comparison with the C/T and T/T genotypes. This PDE4D genotype may lead to accelerated cyclic AMP degradation and subsequently elevated inflammation 1 day after CEA. These observations, in conjunction with previous studies, suggest that elevated inflammatory states may be partially responsible for the development of cognitive dysfunction after CEA, but more investigation is required.
Authors: J Mocco; T F Choudhri; W J Mack; I Laufer; J Lee; S Kiss; A Poisik; D O Quest; R A Solomon; E S Connolly Journal: Neurosurgery Date: 2001-04 Impact factor: 4.654
Authors: Eric J Heyer; Ruchey Sharma; Anita Rampersad; Christopher J Winfree; William J Mack; Robert A Solomon; George J Todd; Paul C McCormick; James G McMurtry; Donald O Quest; Yaakov Stern; Ronald M Lazar; E Sander Connolly Journal: Arch Neurol Date: 2002-02
Authors: E S Connolly; C J Winfree; A Rampersad; R Sharma; W J Mack; J Mocco; R A Solomon; G Todd; D O Quest; Y Stern; E J Heyer Journal: Neurosurgery Date: 2001-11 Impact factor: 4.654
Authors: G J de Borst; F L Moll; H D van de Pavoordt; H W Mauser; J C Kelder; R G Ackerstaf Journal: Eur J Vasc Endovasc Surg Date: 2001-06 Impact factor: 7.069
Authors: C Indolfi; E Di Lorenzo; A Rapacciuolo; A M Stingone; E Stabile; A Leccia; D Torella; R Caputo; F Ciardiello; G Tortora; M Chiariello Journal: J Am Coll Cardiol Date: 2000-07 Impact factor: 24.094
Authors: L J Landells; C M Szilagy; N A Jones; K H Banner; J M Allen; A Doherty; B J O'Connor; D Spina; C P Page Journal: Br J Pharmacol Date: 2001-07 Impact factor: 8.739
Authors: Solveig Gretarsdottir; Sigurlaug Sveinbjörnsdottir; Hjörtur H Jonsson; Finnbogi Jakobsson; Elisabet Einarsdottir; Uggi Agnarsson; Dana Shkolny; Gisli Einarsson; Herdis M Gudjonsdottir; Einar M Valdimarsson; Olafur B Einarsson; Gudmundur Thorgeirsson; Radinka Hadzic; Sif Jonsdottir; Sigridur Th Reynisdottir; Sigrun M Bjarnadottir; Thorunn Gudmundsdottir; Gudrun J Gudlaugsdottir; Ramanjit Gill; Klaus Lindpaintner; Jesus Sainz; Helgi H Hannesson; Gunnar Th Sigurdsson; Michael L Frigge; Augustine Kong; Vilmundur Gudnason; Kari Stefansson; Jeffrey R Gulcher Journal: Am J Hum Genet Date: 2002-02-06 Impact factor: 11.025